OBJECTIVE: The purpose of this meta-analysis was to explore the effect of corticosteroids on atrial fibrillation (AF) following catheter ablation. METHODS: We searched PubMed, Embase, and the Cochrane Central Register of Controlled Trials for published articles describing the effect of corticosteroids in preventing AF recurrence after catheter ablation. Data on study and patient were extracted. Risk ratios (RRs) and 95% confidence intervals (CIs) were calculated by use of a random-effect model, and P values of <0.05 were considered significant. RESULTS: Two randomized controlled trials (RCTs) and three cohort studies involving 846 patients were included in this meta-analysis. Within one month of catheter ablation, corticosteroid use was associated with a declined risk of recurrence of AF in RCT (RR 0.57, 95% CI 0.39 to 0.85, P=0.005), but without significant effect in cohort studies (RR 1.01, 95% CI 0.79 to 1.30, P=0.94). After three months of catheter ablation, corticosteroids did not have a significant effect in the prevention of late recurrence of AF in either RCT (RR 0.78, 95% CI 0.38 to 1.59, P=0.49) or cohort studies (RR 0.96, 95% CI 0.70 to 1.31, P=0.78). CONCLUSIONS: Our meta-analysis suggested that periprocedural administration of corticosteroids of catheter ablation was associated with reduction of early but not late recurrence of AF.
OBJECTIVE: The purpose of this meta-analysis was to explore the effect of corticosteroids on atrial fibrillation (AF) following catheter ablation. METHODS: We searched PubMed, Embase, and the Cochrane Central Register of Controlled Trials for published articles describing the effect of corticosteroids in preventing AF recurrence after catheter ablation. Data on study and patient were extracted. Risk ratios (RRs) and 95% confidence intervals (CIs) were calculated by use of a random-effect model, and P values of <0.05 were considered significant. RESULTS: Two randomized controlled trials (RCTs) and three cohort studies involving 846 patients were included in this meta-analysis. Within one month of catheter ablation, corticosteroid use was associated with a declined risk of recurrence of AF in RCT (RR 0.57, 95% CI 0.39 to 0.85, P=0.005), but without significant effect in cohort studies (RR 1.01, 95% CI 0.79 to 1.30, P=0.94). After three months of catheter ablation, corticosteroids did not have a significant effect in the prevention of late recurrence of AF in either RCT (RR 0.78, 95% CI 0.38 to 1.59, P=0.49) or cohort studies (RR 0.96, 95% CI 0.70 to 1.31, P=0.78). CONCLUSIONS: Our meta-analysis suggested that periprocedural administration of corticosteroids of catheter ablation was associated with reduction of early but not late recurrence of AF.
Authors: Dirk van Osch; Jan M Dieleman; Diederik van Dijk; Kirolos A Jacob; Jolanda Kluin; Pieter A Doevendans; Hendrik M Nathoe Journal: Int J Cardiol Date: 2015-01-08 Impact factor: 4.164
Authors: Konstantinos P Letsas; Reinhold Weber; Gerd Bürkle; Constantinos C Mihas; Jan Minners; Dietrich Kalusche; Thomas Arentz Journal: Europace Date: 2008-11-13 Impact factor: 5.214
Authors: Richard L Amdur; Monica Mukherjee; Alan Go; Ian R Barrows; Ali Ramezani; Jun Shoji; Muredach P Reilly; Joseph Gnanaraj; Raj Deo; Sylvia Roas; Martin Keane; Steve Master; Valerie Teal; Elsayed Z Soliman; Peter Yang; Harold Feldman; John W Kusek; Cynthia M Tracy; Dominic S Raj Journal: PLoS One Date: 2016-02-03 Impact factor: 3.240
Authors: Nicholas G Kounis; Ioanna Koniari; George Tzanis; George D Soufras; Dimitrios Velissaris; George Hahalis Journal: Ann Card Anaesth Date: 2020 Jan-Mar
Authors: Massimiliano Marini; Luigi Pannone; Domenico G Della Rocca; Stefano Branzoli; Antonio Bisignani; Sahar Mouram; Alvise Del Monte; Cinzia Monaco; Anaïs Gauthey; Ivan Eltsov; Ingrid Overeinder; Gezim Bala; Alexandre Almorad; Erwin Ströker; Juan Sieira; Pedro Brugada; Mark La Meir; Gian-Battista Chierchia; Carlo De Asmundis; Fabrizio Guarracini Journal: J Cardiovasc Dev Dis Date: 2022-09-08